Cover Image
市場調查報告書

Risperidone的中國市場:2010年∼2019年

Investigation Report on China Risperidone Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 337514
出版日期 內容資訊 英文 40 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Risperidone的中國市場:2010年∼2019年 Investigation Report on China Risperidone Market, 2010-2019
出版日期: 2015年08月18日 內容資訊: 英文 40 Pages
簡介

Risperidone主要是治療思覺失調症所採用的抗精神病藥。2005年僅3,800萬人民幣的中國Risperidone銷售額到2014年已達到1億300萬人民幣,其中48%為Xian Janssen Pharmaceutical Ltd所佔。

本報告提供中國的Risperidone的專利及核準情況,提供您銷售額·銷售量的變化與預測,價格趨勢,主要的製藥公司及其市場佔有率,競爭環境與其展望,還有主要製造商的簡介等資訊。

第1章 Risperidone的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國的Risperidone的市場簡介

  • 專利·核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國的Risperidone銷售情形

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國的主要Risperidone製造商市場佔有率

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國的Risperidone的劑型的相關調查

  • 各劑型的市場佔有率:以銷售額為準
  • 各劑型的市場佔有率:以銷售量為準

第6章 中國的醫院的Risperidone的標準價格

  • Xian Janssen Pharmaceutical Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd
  • Shandong Qilu Pharmaceutical Co., Ltd
  • Changzhou Siyao Pharmaceutical Co., Ltd
  • Jiangsu Nhwa Pharmaceutical Co., Ltd
  • Zhejiang Huahai Pharmaceutical Co., Ltd

第7章 中國市場中Risperidone的主要製藥公司

  • Xian Janssen Pharmaceutical Ltd.
  • Zhejiang Huahai Pharmaceutical Co., Ltd
  • Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd
  • Shandong Qilu Pharmaceutical Co., Ltd
  • Changzhou Siyao Pharmaceutical Co., Ltd
  • Jiangsu Nhwa Pharmaceutical Co., Ltd

第8章 中國的Risperidone的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1508297

Risperidone is a new antipsychotic drug mainly used to treat both positive and negative symptoms of schizophrenia. It has antagonistic fast actions at 5-HT receptor when given at low doses and at dopamine D2 receptor when given at high doses. And it takes only one hour for risperidone to reach its peak. And it has a long half-life of 3 hours. The metabolite of risperidone is 9-hydroxyrisperidone which has pharmacological activity and a half-life of 24 hours. And risperidone mainly undergoes renal excretion.

As risperidone exerts little and reversible influence on electrocardiogram, it is of little toxicity to heart in treating schizophrenia. Risperidone is not only effective in ameliorating psychological symptoms of dementia but also advantageous in improving illusion, behavior disorder, aggressive behavior and cognitive function with little adverse effects. Therefore it is worthy of further application.

China now faces a series of complex and urgent medical demand. With lifestyle changes and pressure brought about by economic development, the number of people suffering from mental disorder goes up to over 100 million in China, which boosts the demand for antipsychotic. Meanwhile, with ageing population, dementia patients grow in number, increasing the demand for drugs that can ameliorate psychological symptoms.

According to CRI's market survey, the annual sales of risperidone increased from CNY 38 million in 2005 to CNY 103 million in 2014. And Xian Janssen Pharmaceutical Ltd. had the largest market share of about 48% for sales value in 2014.

The market size of risperidone is expected to keep growing in the next few years in China.

Readers can get at least the following information through this report:

  • market size of risperidone in China
  • competitive landscape of risperidone market in China
  • price of risperidone made by different enterprises in China
  • market outlook of risperidone in China

The author suggests the following groups of people purchase this report:

  • antipsychotic manufacturers
  • investors/research institutions interested in Chinese medicine market
  • -any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Risperidone

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Risperidone in China

  • 2.1. Patent and Approval Information of Risperidone in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Risperidone Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Risperidone Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Risperidone in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Risperidone in Chinese Hospitals in 2014

  • 6.1. Xian Janssen Pharmaceutical Ltd.
  • 6.2. Janssen Pharmaceuticals, Inc.
  • 6.3. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd
  • 6.4. Shandong Qilu Pharmaceutical Co., Ltd
  • 6.5. Changzhou Siyao Pharmaceutical Co., Ltd
  • 6.6. Jiangsu Nhwa Pharmaceutical Co., Ltd
  • 6.7. Zhejiang Huahai Pharmaceutical Co., Ltd

7. Major Manufacturers of Risperidone in Chinese Market, 2010-2014

  • 7.1. Xian Janssen Pharmaceutical Ltd.
  • 7.2. Zhejiang Huahai Pharmaceutical Co., Ltd
  • 7.3. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd
  • 7.4. Shandong Qilu Pharmaceutical Co., Ltd
  • 7.5. Changzhou Siyao Pharmaceutical Co., Ltd
  • 7.6. Jiangsu Nhwa Pharmaceutical Co., Ltd

8. Market Outlook of Risperidone in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Information of Risperidone in China
  • Chart Approval Information of Risperidone in China
  • Chart Risperidone Sales in China
  • Chart Sales Value of Risperidone in China, 2010-2014
  • Chart Sales Value of Risperidone in Some Regions in China, 2010-2014
  • Chart Sales Volume of Risperidone in China, 2010-2014
  • Chart Sales Volume of Risperidone in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Risperidone Manufacturers for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Made by Xian Janssen in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Made by Janssen (Belgium) in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Made by Changzhou Siyao in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Made by Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Made by Other Enterprises in China, 2010-2014
  • Chart Market Share of TOP5 Risperidone Manufacturers for Sales Volume in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Injection in China, 2010-2014
  • Chart Sales Value and Market Share of Oral Risperidone Solution in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Tablet in China, 2010-2014
  • Chart Sales Value and Market Share of Risperidone Capsule in China, 2010-2014
  • Chart Price of Risperidone Made by Xian Janssen in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Janssen (Belgium) in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Qilu in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Changzhou Siyao in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Jiangsu Nhwa in Some Chinese Cities in 2014
  • Chart Price of Risperidone Made by Zhejiang Huahai in Some Chinese Cities in 2014
Back to Top